Amylyx Pharmaceuticals, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 06/08/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 06/08/2026 | Sep 2024Filed 06/11/2025 | Jun 2024Filed 06/11/2025 | Mar 2024Filed 06/11/2025 |
|---|---|---|---|---|---|---|---|---|
| — | — | $0 | $0 | $0 | $0.4 | −$1 | $89 | |
| −$43 | −$41 | −$34 | −$41 | −$36 | −$73 | −$73 | −$119 | |
| −$0.39 | −$0.37 | −$0.37 | −$0.46 | −$0.42 | −$1.07 | −$1.07 | −$1.75 | |
| 111 | 111 | 93 | 89 | 86 | 68 | 68 | 68 |
Trend